ロード中...

Effects of High‐ and Low‐Fat Meals on the Pharmacokinetics of Ozanimod, a Novel Sphingosine‐1‐Phosphate Receptor Modulator

Ozanimod (RPC1063) is an oral selective modulator of the sphingosine‐1‐phosphate 1 and 5 receptors under development for the treatment of relapsing multiple sclerosis and inflammatory bowel disease. The effects of high‐fat and low‐fat meals on the pharmacokinetics (PK) of a single oral dose of ozani...

詳細記述

保存先:
書誌詳細
出版年:Clin Pharmacol Drug Dev
主要な著者: Tran, Jonathan Q., Hartung, Jeffrey P., Tompkins, Cindy‐Ann, Frohna, Paul A.
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6099448/
https://ncbi.nlm.nih.gov/pubmed/29125718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.409
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!